Should diabetic women with breast cancer have their own intervention studies?
- Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, 420 Delaware Street SouthEast, MMC 480, Minneapolis, Minnesota 55455-0392, USA
- (Correspondence should be addressed to D A Potter; Email: dapotter{at}umn.edu)
Abstract
This commentary on ‘Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity’ by Nogueira et al., published in this issue of Endocrine-Related Cancer, addresses the challenges of translating diet, exercise, and pharmacologic trials in diabetic mouse mammary tumor models to human studies. We propose that trials specifically designed to test such interventions in diabetic women with breast cancer would be valuable and informative.
- Revision received 8 December 2011
- Accepted 15 December 2011
- Made available online as an Accepted Preprint 16 December 2011
- © 2012 Society for Endocrinology
